# Karyopharm Therapeutics Inc. – FDA Inspection, Feb 8, 2017

Source: https://www.keypedia.com/records/fda_inspections/karyopharm-therapeutics-inc/8eb40be4-18ba-41d3-b5de-ba4c4b35c3b5
Source feed: FDA_Inspections

> FDA inspection 1009153 of Karyopharm Therapeutics Inc., February 08, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009153
- Company Name: Karyopharm Therapeutics Inc.
- Inspection Date: 2017-02-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1202243 - 2023-03-15
- FDA Inspection 1122926 - 2020-02-28

## Related Officers

- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/darin-s-wiegers/5bf03f8b-1571-4845-916d-3211d72d97a2)
- Issuing Officer

Company: https://www.keypedia.com/companies/karyopharm-therapeutics-inc/28ffa225-b02c-40a0-8662-5bed25336a5a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c